Grossi Federico 4
4 · Apellis Pharmaceuticals, Inc. · Filed Mar 2, 2022
Insider Transaction Report
Form 4
Grossi Federico
See Remarks
Transactions
- Sale
Common Stock
2022-03-01$43.53/sh−375$16,324→ 109,811 total
Footnotes (1)
- [F1]This is a scheduled sale from 10B5-1 trading plan.